Pubertal delay in patients with paternally derived 15q11.2–q13 duplication syndrome and MKRN3 overexpression

Clicks: 26
ID: 329120
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #78 of 449 articles by views in the journal of clinical endocrinology & metabolism

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 449 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Context Duplications of the 15q11.2–q13 region are primarily associated with neurodevelopmental disorders, while their endocrine implications remain poorly defined. The imprinted gene MKRN3, located within this locus, inhibits pubertal onset, and loss-of-function variants cause central precocious puberty. However, the clinical impact of increased MKRN3 dosage remains unclear. This study investigates whether paternally derived 15q11.2–q13 duplications lead to MKRN3 overexpression and are associated with delayed pubertal maturation. Materials and Methods Four patients with confirmed paternal 15q11.2–q13 duplications were retrospectively evaluated. Clinical, auxological, hormonal, and radiological data were collected. Genetic characterization was performed using MS-MLPA, array-CGH, and whole-exome sequencing when possible. MKRN3 expression was assessed by RT-qPCR in peripheral blood samples and compared with Tanner and sex-matched controls. Results All patients showed duplications involving the 15q11.2–q13 region with confirmed paternal origin. RT-qPCR showed increased MKRN3 expression in three of the four patients, supporting a potential gene dosage effect. Clinically, patients presented with pubertal abnormalities ranging from delayed puberty with slow progression to hypogonadotropic hypogonadism. Longitudinal data in one patient showed that MKRN3 expression levels during pubertal progression remained elevated compared to controls at both timepoints. In one case, a variant in PROKR2 may have contributed to phenotype. Conclusion Paternally derived 15q11.2–q13 duplications are associated with MKRN3 overexpression and delayed pubertal maturation. These findings suggest for the first time in humans a link between increased MKRN3 dosage and pubertal delay, expanding the phenotypic spectrum of dup15q syndrome and highlighting the importance of endocrine monitoring in affected individuals.
Reference Key
openalex_W7213560995 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Delfina Petrone, Stefania Palumbo, Carola Giacobbe, Maria Elena Onore, Maria Esposito, Silverio Perrotta, Emanuele Miraglia del Giudice, Giulio Piluso, Vincenzo Nigro, Claudia Santoro, Anna Grandone
Are you one of these authors? Claim your profile
Journal the journal of clinical endocrinology & metabolism
Year 2026
DOI
10.1210/clinem/dgag385
URL
https://doi.org/10.1210/clinem/dgag385
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.